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Abstract 
Oxygenation-sensitive spin relaxation time T2' and relaxation rate R2' (1/T2') are presumed to 
be markers of the cerebral oxygen extraction fraction (OEF) in acute ischemic stroke. In this 
study we investigate the relationship of T2'/R2' with dynamic susceptibility contrast-based 
relative cerebral blood flow (rCBF) in acute ischemic stroke to assess their plausibility as 
surrogate markers of ischemic penumbra. Twenty-one consecutive patients with internal 
carotid artery and/or middle cerebral artery occlusion were studied at 3.0 T. A physiological 
model of the cerebral vasculature (VM) was used to process PWI raw data in addition to a 
conventional deconvolution technique. T2', R2' and rCBF values were extracted from the 
ischemic core and hypoperfused areas. Within hypoperfused tissue, no correlation was found 
between deconvolved rCBF and T2' (r=-0.05, p=0.788), or R2' (r=0.039, p=0.836). In 
contrast, we found a strong positive correlation with T2' (r=0.444, p=0.006) and negative 
correlation with R2' (r=-0.494, p=0.0025) for rCBFVM, indicating increasing OEF with 
decreasing CBF and that rCBF based on the vascular model may be more closely related to 
metabolic disturbances. Further research to refine and validate these techniques may enable 
their use as MRI-based surrogate markers of the ischemic penumbra for selecting stroke 
patients for interventional treatment strategies.    
 
Keywords: brain imaging - MRI - oxygen metabolism - perfusion-weighted imaging - tissue 
at risk 
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Introduction 
In acute ischemic stroke, the concept of a tight coupling of cerebral blood flow (CBF) 
reduction and increase of cerebral oxygen extraction fraction (OEF) within the still viable 
tissue at risk of infarction (ischemic penumbra)1-3 has led to growing research on oxygen-
sensitive magnetic resonance imaging (MRI) techniques4-6, especially because widely-used 
perfusion-weighted imaging (PWI) parameters including time to peak (TTP) and mean transit 
time (MTT) maps alone cannot be used to discriminate between real tissue at risk (ischemic 
penumbra) and benign oligemia reliably7, 8. Apart from inherent technical issues of PWI, this 
problem is due to the fact that perfusion maps used in ischemic stroke only depict different 
degrees of perfusion impairment without considering metabolic factors including OEF that 
characterize the ischemic penumbra8. Although the infarct volume at admission has been 
shown to be the main determining factor of outcome after endovascular therapy9, a reliable 
image-based surrogate of the penumbra could be helpful for therapeutic decision-making10, 
e.g. when the time of symptom onset is not known or when patients display transient or 
fluctuating symptoms despite a persistent vessel occlusion.  
 
Quantitative T2' and R2' (1/T2') mapping, where T2' basically represents the effective 
transverse relaxation time (T2*), corrected for spin-spin effects (1/T2'=1/T2*-1/T2), are 
sensitive to locally increased concentrations of paramagnetic deoxygenated hemoglobin 
(Hb)11, 12. A shift in global Hb ratio towards elevated concentrations of deoxygenated Hb 
results in a decrease/increase of T2'/R2', respectively. Theoretically, R2' (1/T2') should be 
proportional to the product of relative OEF and relative cerebral blood volume (rCBV) 
multiplied with a tissue-specific constant13 and thus be suitable to detect OEF increases. 
Significantly decreased T2' values have been reported within hypoperfused tissue with 
delayed time-to-peak (TTP) in acute ischemic stroke. These data were interpreted as the 
consequence of increased OEF due to impaired perfusion14, 15. While T2' values were 
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significantly decreased in the infarct core and the hypoperfused tissue, no correlation between 
T2' and TTP delay could be found15. This suggested that the TTP delay alone is not an 
appropriate surrogate of cerebral oxygen extraction fraction, and therefore, does not allow for 
the differentiation between benign oligemia and penumbra in ischemic stroke. Even though 
TTP maps allow for rapid delineation of perfusion abnormalities by indicating any delay in 
arterial input and dispersion of the bolus, they provide rather unspecific information regarding 
local tissue perfusion. Consequently, CBF as the actual promoter of OEF alterations - which 
are assumed to cause T2' changes - may show large variability within hypoperfused areas with 
TTP delay16.  
 
The calculation of relative (r)CBF values from dynamic susceptibility contrast (DSC) imaging 
which depends on scaling factors determined by the postprocessing algorithm underlies some 
complexities and potential sources of error in raw data postprocessing. First, the widespread 
deconvolution techniques are prone to a high level of noise (yielding a low signal-to-noise 
ratio, SNR) which is generally present in the concentration-time curves obtained from DSC-
MRI. Consequently, the tissue response (residue) function produced by deconvolution is 
naturally irregular17. Furthermore, the usual occurrence of a delay between the arterial input 
function (AIF) and the observed concentration-time curve can be problematic for DSC-MRI 
analysis. All these factors may result in an underestimation of rCBF and raise problems for 
the estimation of flow heterogeneity in DSC-MRI, particularly at low SNR17. The reliability 
of DSC-based rCBF can be improved by using for the calculations a physiological model of 
the perfusion dynamics of the cerebral microvasculature which produces a smoother, 
monotonically decreasing estimate of the residue function and is more robust to the delay 
between the AIF and the tissue concentration-time curve17, 18. Those maps might be used to 
assess an rCBF decrease in acute large vessel occlusion more reliably. Furthermore, if it can 
be shown that there is a correlation between CBF reduction and decrease of T2' as a marker of 
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increased OEF in ischemic stroke, CBF alone could be used to better distinguish between 
oligemia and penumbra than TTP maps that are currently used in clinical routine.  
 
In this study, rCBF together with T2'/R2' in ischemic brain tissue during acute cerebral artery 
occlusion was investigated as a surrogate of the ischemic penumbra. It should be stressed that 
these data comprise high-resolution T2’/R2’ maps and DSC-based PWI data acquired on a 
highly-selected patient collective with acute cerebral artery occlusion prior to 
revascularization procedures (intravenous thrombolysis and/or endovascular thrombectomy). 
Data to assess the relationship between oxygen-sensitive T2'/R2' and rCBF were acquired in 
the acute phase of ischemic stroke by combining conventional PWI data with quantitative 
maps of T2 and T2* to calculate the oxygen-sensitive relaxation parameters T2'/R2', 
following motion-correction with a custom-built algorithm. Because of the limited validity of 
conventionally generated rCBF-maps that are based on singular value deconvolution, a 
potentially more reliable method for obtaining the rCBF from DSC perfusion data was used. 
The combination of oxygen-sensitive parameters with blood flow measurements aimed at the 
confirmation that these methods may enable non-invasive assessment of the ischemic 
penumbra in acute ischemic stroke. Thus, the study is a contribution to the overall effort to 
investigate oxygen metabolism with MRI methods exploiting the Blood Oxygen Level 
Dependent (BOLD) contrast which is based on the susceptibility differences between 
deoxyhemoglobin and oxyhemoglobin4, 6.    
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Materials and Methods 
Patients  
Twenty-one consecutive patients with acute stroke due to proximal artery occlusion of the 
anterior circulation were included in this prospective study within the study period (June 2013 
to December 2014). Parts of this patient population as well as the inclusion criteria were 
described in more detail and published previously15. Written informed consent was obtained 
from each patient or their legal representative before inclusion in the study. All patients 
received intravenous thrombolysis after the exclusion of intracerebral hemorrhage and other 
contraindications. The study was approved by the Institutional Review Board of the medical 
faculty of the Goethe University (Approval number: 275/12) and was performed in 
accordance with the Declaration of Helsinki. Potential eligibility for thrombectomy was 
evaluated using a standardized MRI protocol.  
 
MR Imaging Protocol 
MRI data were acquired on a 3 Tesla whole-body scanner (Magnetom Verio 3T; Siemens 
Healthcare, Erlangen, Germany), equipped with a body transmit and an 8-channel phased 
array head receive coil. The total measurement time was 20:51 minutes. Data acquisition 
followed a protocol described previously15. 
 
Diffusion-weighted images (DWI) were acquired with a single-shot spin-echo echo-planar 
imaging (EPI) sequence, using the following parameters: echo time TE=88 ms, repetition time 
TR=4900 ms, field-of-view 220×220 mm2, matrix size 130×130, 25 axial slices, slice 
thickness 5 mm, inter-slice gap 0.5 mm, bandwidth BW=1425 Hz/Px, and b=1000 s/mm2. 
ADC maps were calculated using the commercially available scanner software.  
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Perfusion-weighted images (PWI) were acquired with a dynamic susceptibility contrast 
gradient-echo (GE) EPI sequence. Imaging parameters were TE=30 ms, TR=1500 ms, flip 
angle FA=90°, field-of-view 230×230 mm2, matrix size 128×128, 19 axial slices, slice 
thickness 4 mm, 1.2 mm inter-slice gap, BW=1447 Hz/Px. The intravenous contrast agent 
gadobutrol (0.1 mmol/kg; Gadovist® Bayer) was automatically applied by a power injector at 
a flow rate of 5 mL/s, followed by a bolus (20 mL) of 0.9% saline. The scanner software 
package was used to calculate time-to-peak (TTP) maps. 
 
The sequence for quantitative T2* mapping has been described in detail in Nöth et al. 201419. 
In summary, a multislice, multi-GE sequence was used that samples a total of 8 GE per 
excitation via successively inverting the readout gradient. Echoes were sampled under the 
same readout gradient polarity to avoid artifacts. Imaging parameters were: linear TE increase 
from 10 to 52 ms with a constant increment of 6 ms, TR=1500 ms, FA=30°, field-of-view 
(FoV) 240×180 mm2, matrix size 192×144 (readout×phase encoding), 25 axial slices, slice 
thickness 2 mm, no inter-slice gap, BW=299 Hz/Px, measurement time 3:36 minutes. For the 
suppression of motion artefacts, this acquisition was repeated twice with reduced spatial 
resolution and thus restricted k-space coverage in phase encoding direction and 6 initial 
dummy scans to achieve steady state conditions. In detail, the first (second) repetition covered 
50% (25%) of central k-space lines and had a measurement time of 1:57 min (1:03 min).  
 
For quantitative T2 mapping, a turbo spin-echo sequence with four different TE values was 
used. Geometrical parameters (FoV, matrix size, slice number, thickness and gap) were 
identical to the T2* protocol with full k-space coverage as listed above. To speed up data 
acquisition, the turbo spin-echo sequence acquired per excitation 11 spin echoes with different 
phase encoding via sending a series of refocusing pulses with a spacing of 16 ms. No other 
acceleration techniques were used.  Further sequence parameters were TR=4670 ms, BW=100 
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Hz/Px, 180° refocusing pulses. Four data sets were acquired, where the echo covering central 
k-space occupied either the first, fourth, sixth, or eighth position in the echo train, thus 
yielding TE values of 16, 64, 96, and 128 ms. 
 
Image Processing and Analysis 
To reduce subject (head) motion artifacts, images for T2* mapping were subjected to a 
previously described motion artifact suppression algorithm19. T2' maps were calculated as 
previously explained in detail15. R2' maps were calculated applying the relationship 
1/T2'=R2'. Voxels with a large fraction of cerebrospinal fluid (CSF) were excluded by 
applying an empirical upper threshold of ≤300 ms to the T2' maps, nulling all voxels beyond 
this value. Accordingly, for the R2' maps, a lower threshold of ≥3.33 s-1 was chosen. 
 
All data were skull-stripped using ‘BET’20 which is part of FSL (FMRIB Software Library, 
http://www.fmrib.ox.ac.uk). DWI data were linearly coregistered to the T2* maps using 
‘FLIRT’21. As the ADC maps intended for further analysis do not provide sufficient anatomic 
contrast for precise coregistration the first diffusion-weighted image (b=0, purely T2-
weighted) was coregistered to the first T2*-weighted image. Afterwards, the resulting 
coregistration matrix was applied to the ADC map. Since all images were acquired in an 
emergency setting, thus being potentially affected by subject movement during the scanning 
process, the 4-dimensional (4D) PWI raw data were retrospectively motion-corrected, using 
‘MCFLIRT’21 prior to coregistration in order to minimize the impact of motion-related 
artifacts on the perfusion maps. Apart from motion correction this tool was used to calculate 
parameter maps based on mean value, standard deviation and signal variance across the entire 
perfusion time series. For coregistration, the first three volumes were extracted from the T2*-
weighted time series using FSL roi, since these could be assumed to provide adequate contrast 
between grey and white matter for coregistration. The mean value of these three volumes was 
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calculated using FSL maths and used for linear coregistration to the T2* reference of the T2* 
mapping. The coregistration matrix of this step was saved and used for coregistering the final 
perfusion maps to the T2* data.  
 
In order to reliably determine the shape of the arterial input function (AIF), voxels containing 
large arteries had to be extracted from the PWI time series. In a first step, the T2*-weighted 
time series were thresholded by applying a lower threshold of 70 % of maximum signal 
intensity to the time series, using FSL maths. Afterwards, the standard deviation maps 
obtained with ‘MCFLIRT’ were divided by the mean value maps to calculate coefficient of 
variation (CoV) maps. These CoV maps were thresholded using a lower threshold of 0.5, thus 
leaving voxels with a relatively high temporal signal intensity variation which is expected to 
indicate the presence of blood vessels. The threshold values had to be adjusted occasionally in 
order to retain a reasonable amount of voxels after the thresholding and masking procedure. A 
binary mask was created, based on the thresholded CoV map and used to mask the 
thresholded signal intensity maps, yielding a map indicating areas of increased temporal 
signal variation for each patient (Figure 1, A). Besides the cerebral arteries these maps 
contained voxels belonging to cerebral veins and CSF. Therefore a mask covering the basal 
frontal lobes, the basal cisterns and the Sylvian fissure was created in standard space (MNI 
152 2 mm, http://www.bic.mni.mcgill.ca/ServicesAtlases/) and used to mask out large 
cerebral veins and the ventricles. During the coregistration of the standard space vessel mask 
to the thresholded signal intensity mask, nearest neighbour interpolation was used to maintain 
the binary character of the mask. This procedure avoids reslicing the data which might affect 
parameter values due to interpolation effects. Finally, the resulting vessel masks were 
separated in the median plane to obtain artery masks for each side separately and used to 
mask the thresholded and masked time series. The final artery maps of the unaffected side 
(contralateral to the vessel occlusion) (Figure 1, B) were used to determine the shape of the 
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arterial input function (AIF). Using MATLAB, the mean value of all voxels in these artery 
maps along the fourth dimension (over time) was taken as a vector and subsequently, this 
vector was applied to every voxel of the time series. As a consequence, many voxels used for 
the determination of the AIF were derived from the more distal parts (M2 and M3 segments) 
of the MCA. Compared to selecting voxels from the proximal part of the MCA, this approach 
has been shown to be advantageous concerning SNR and the reliability of values measured in 
DSC-based perfusion maps22. Finally, the resulting AIF was converted to a 4D file with 
uniform AIF for the whole brain to be used for processing the PWI raw data in order to 
generate rCBF maps using ‘VERBENA’ which is part of the FSL toolbox18. The vascular 
model included in this tool produces a smooth, monotonically decreasing estimate of the 
residue function. Furthermore, the residue function estimate is characterized by only two 
parameters, which can be used to assess how the shape of the residue function varies among 
brain regions. In addition to the calculation of rCBF maps (Figure 1, C) based on the vascular 
model, this tool was used to automatically correct for contamination with macrovascular 
components in voxels (e.g. caused by susceptibility effects of vessels nearby)18. Finally, the 
blood vessel mask (Figure 1, A) was used to remove larger blood vessels from the corrected 
rCBF maps (Figure 1, D). Consequently, the resulting maps predominantly contain 
information on rCBF within the microvasculature. To assess the differences between rCBF 
maps based on the vascular model (rCBFVM) and conventional maps as used in clinical 
routine, rCBF maps were also generated based on singular value deconvolution (rCBFSVD) 
using the scanner’s software. AIFs for these maps were derived from two different sites 
frequently used in the clinical setting through selection of 5 to 10 voxels by an experienced 
neuroradiologist (M.W.): from the basal ganglia (tissue AIF) and the MCA trunk (vascular 
AIF) contralateral to the occlusion. Both rCBFVM and rCBFSVD maps were linearly 
coregistered to the T2* data. 
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T2'/R2' and rCBF values were extracted from the ischemic core which was operationally 
defined by applying a threshold of <550×10-6 mm2/s on the ADC maps (Figure 2, upper row) 
and the perfusion-restricted MCA-dependent territory defined by the TTP lesion (Figure 2, 
upper row). The latter was traced manually (A.S.). For maximal spatial coverage, ADC and 
TTP lesions were delineated in every slice using FSL view. In the case of overlapping lesions, 
the ADC lesion was subtracted from the PWI lesion for thorough separation of tissue 
compartments and to receive the ADC/PWI mismatch area (Figure 2, upper row). To account 
for regional flow heterogeneity within the hypoperfused area, further regionalization of the 
TTP lesion was done by subdividing the lesion along the y-axis (anterior-posterior direction) 
into three relatively equally sized regions-of-interest (ROIs) with a rostral, a middle and a 
dorsal ROI (Figure 2, upper row). This approach ensured the comparability between ROIs 
including relatively equal proportions of grey and white matter (that differ regarding T2'/R2' 
values) while retaining the large ROIs that are required due to the relatively low SNR of 
T2'/R2' maps. Furthermore, this method of regionalization with a territorial pattern respecting 
the distribution of leptomeningeal collaterals, should allow for estimation of flow 
heterogeneity due to different degrees of collateralization. Mean rCBF and T2'/R2' values of 
non-zero voxels (Figure 2, lower row) were extracted from all defined ROIs using FSL stats 
and compared to values from corresponding normoperfused areas after mirroring the ROIs to 
the contralateral side.  
 
Data evaluation and assessment for artifacts 
Since both quantitative imaging (especially T2*) and PWI are prone to artifacts induced by 
subject motion, we performed several analyses to evaluate data quality and to investigate the 
potential presence of misleading artifacts. First of all, an in-depth visual inspection of the 
quantitative raw data and the PWI timeseries was performed. Quantitative T2* maps were 
assessed for artifacts based on the correlation of T2* with the anatomical T2 reference and the 
12 
 
dispersion of values around the mean (Supplementary material for details). For PWI, AIFs 
were selected for final analysis based on subjective criteria such as an early and steep drop in 
the signal time curve S(t), a limited amount of background noise, a smooth shape of the curve 
and a quick signal return to baseline as these parameters contribute to a clearly discernible 
signal drop due to bolus-passage. The Supplemental figure I shows an example for a 
representative patient. These characteristics were objectified by applying appropriate 
quantitative measures to the signal-time curves (Supplementary material for details).  
 
Statistical analysis   
Since the parameters were not normally distributed, only non-parametric statistical testing 
was used. The Wilcoxon-signed rank test was used to compare T2', R2' and rCBF between the 
defined ROIs inside the affected regions and inside the corresponding control areas of the 
unaffected hemisphere. Spearman’s rank correlation was used for the evaluation of parameter 
correlation. A value of p<0.05 was considered significant. Statistical analysis was performed 
with SPSS 23 (IBM SPSS Statistics; SPSS Inc, Armonk, NY). Correction for multiple 
statistical testing using False Discovery Rate (FDR) correction was performed. 
 
Results 
Out of 21 patients, 15 patients provided PWI raw data and T2'/R2' maps with a reasonable 
quality for further analysis, whereas six patients had to be excluded due to pronounced 
motion-related artifacts in the quantitative maps (n=4) or insufficient bolus arrival on PWI 
(n=2) (Supplementary material (Supplemental table I and Supplemental figures II-V) for 
details). After further quantitative evaluation of the PWI data, a further four patients had to be 
excluded, due to insufficient peak salience and a high noise level in the 4D AIF file 
(Supplementary material (Supplemental table II and Supplemental figures V and VI) for 
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details) that was used for calculation of rCBFVM maps in order to only include patients for 
which reliable rCBFVM data could be expected. Thus, 11 patients (4 male, mean age 69 ± 12.9 
years) were left for final analysis. A schematic overview of the different data processing steps 
and patient selection for final analysis is given in Figure 3. Mean time from symptom onset to 
MRI was 264 ± 63 minutes. Demographic and basic clinical data for each patient are given in 
Table 1.  
 
The method of AIF selection did not significantly influence rCBFSVD values. Therefore, only 
the values calculated with the tissue AIF are given in the graphs. Changes of T2'/R2' were 
most pronounced within the ischemic core and statistically significant for all ROIs. Mean 
values for T2'/R2' and rCBFVM data are given in Table 2. Within the ischemic core, no 
significant correlation between T2'/R2' and rCBFVM could be found (r=-0.218, p=0.519 and 
r=-0.018, p=0.958). In the entire mismatch area (TTP minus ADC lesion), a significant 
positive correlation between T2' and rCBFVM (r=0.685, p=0.01, Figure 4 A) and a significant 
negative correlation between R2' and rCBFVM (r=-0.685, p=0.01, Supplemental figure VII A) 
were found. For rCBFSVD, no significant correlations with either T2' (r=0.327, p=0.326) or 
R2' (r=-0.327, p=0.326, Figure 4 B and Supplemental figure VII B) were found. When 
analyzing the relationship of T2'/R2' and rCBFVM within the subdivided mismatch area there 
was a strong significant positive correlation between T2' and rCBFVM (r=0.444, p=0.006, 
Figure 4 C) and a corresponding negative correlation between R2' and rCBFVM (r= -0.494, 
p=0.0025, Supplemental figure VII C).  Conventional rCBFSVD did not correlate with T2' or 
R2' (r=-0.05, p=0.788 and r=0.039, p=0.836, Figure 4 and Supplemental figure VII, panels 
D). In general, the relative rCBF reduction within hypoperfused tissue as compared to the 
corresponding contralateral areas was lower for rCBFVM than for rCBFSVD (22.46 ± 17.82 % 
vs. 48.58 ± 16.58 %, p=0.0001) (Supplemental figure VIII).  FDR correction was performed 
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for the respective parameters and the corrected level of significance was p=0.044. 
Consequently, all results remained significant after FDR correction. 
 
Discussion 
This study examined the relationship between T2'/R2' and rCBF, the latter being determined 
by applying both widely-used SVD and a physiological model of the cerebral 
microvasculature. Although T2' and R2' can be expected to provide similar information, we 
measured both parameters in order to ensure comparability to previous studies. To the very 
best of our knowledge, this is the first study correlating oxygenation-sensitive motion-
corrected T2' and R2' mapping with rCBF measurements in patients with acute large vessel 
stroke.  
 
Endovascular therapy offers an opportunity for more individualized acute stroke treatment, 
yielding a therapeutic option for patients with symptom duration extending beyond 
conventional time windows. Besides a thorough evaluation of clinical symptoms, their 
dynamics over time and the vessel status, knowledge about the salvageable amount of tissue 
may be crucial for decision making in these situations. This requires estimation of oligemia 
and penumbra, which is defined by an increased OEF indicating metabolic stress2. The 
concept of the penumbra was established based on PET studies which found the OEF increase 
to be its hallmark2. Currently, efforts are made to develop MR parameters to measure the 
fraction of oxygen extracted from the blood. Although this fraction was not measured in this 
study, the term OEF is used to describe the underlying physiological processes for 
oxygenation changes in ischemic tissue.     
 
TTP maps that can easily be obtained via the scanner’s software have the advantage of rapidly 
providing information on perfusion delay in an affected territory – which we also used in the 
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present study to delineate the vascular territory with an occluded source artery and to define 
the relevant ROIs. However, while TTP maps are frequently used in the clinical setting to 
estimate the amount of tissue at risk of infarction - usually by applying threshold values23, 24 - 
they do not supply reliable information on regional blood flow conditions16. Besides a 
regionally heterogeneous reduction of CBF in these areas, CBF in tissue around an occluded 
vessel might actually also be elevated due to increased perfusion via collaterals or in the case 
of early (partial) reperfusion16. Especially the latter scenario may be masked by the delay of 
contrast input within the territory of an occluded artery and might therefore not be accounted 
for in TTP maps. Moreover, perfusion abnormalities as depicted by TTP maps have been 
shown to lack agreement with positron emission tomography (PET)-based OEF increases7 as 
well as MRI-based surrogates of OEF elevations, namely T2'15. These findings suggest that a 
TTP delay does not necessarily indicate a CBF reduction which provokes a compensatory 
OEF increase if blood flow is below the oligemic threshold. This suggests that through 
measuring T2'/R2' in areas with TTP delay their potential to detect OEF increase is elucidated 
rarely and that a correlation with parameters that better reflect local hemodynamics and 
perfusion pressure is required, not only for judging pathophysiological plausibility of T2'/R2' 
changes as surrogates of OEF elevations, but also for the implementation of techniques that 
allow for an improved estimation of penumbra and oligemia in the clinical setting. The 
physiological model of the cerebral vasculature used in this study is expected to allow for 
representation of blood flow heterogeneity25.   
 
In this study, a significant positive correlation between T2' and rCBFVM within the MCA-
dependent territory was demonstrated. After further regionalization of the DWI/PWI 
mismatch region to analyze the association in more circumscribed compartments respecting 
heterogeneity of the respective parameters within the relatively large mismatch area, 
correlations with rCBFVM were significant for both T2' and R2', again showing a positive 
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correlation between T2' and rCBFVM, while R2' correlated negatively with rCBFVM. These 
results suggest an incremental deoxygenation of Hb as the consequence of an elevated OEF 
with decreasing rCBF within the hypoperfused tissue, leading to higher concentrations of 
deoxygenated Hb and thus decreased T2' and increased R2'. These results are in line with a 
previous study by Jensen et al. that demonstrated a significant correlation of T2' values and 
rCBF in a rat model of middle cerebral artery occlusion and reperfusion26. Furthermore, a 
positive correlation of T2' (negative for R2') with DSC-based relative cerebral blood volume 
(rCBV) which is known to decrease as a linear function of rCBF in acute stroke27, has been 
shown in a previous work on patients with ICA and MCA occlusion28. Christen et al. found a 
positive correlation of MR-derived R2'-based cerebral oxygen saturation measurements with 
both rCBF and rCBV in healthy subjects29. Since these calculated oxygen saturation values 
are assumed to be reciprocally proportional to R2'29, the results obtained in this study can be 
considered as a confirmation of their findings under pathological conditions in relevantly 
hypoperfused brain tissue. Interestingly, conventional rCBFSVD values which generally 
showed a higher estimation of the degree of hemodynamic impairment (Supplemental figure 
II) did not correlate significantly with T2'/R2' values (Figure 4, C and D). This finding 
suggests that the vascular model streamlined to brain tissue and the cerebral microcirculation 
by correction for macrovascular components is more appropriate to reflect different degrees 
of local metabolic stress and alterations of OEF.   
 
Our findings indicate that changes of T2' and R2' in ischemic stroke reflect alterations of OEF 
and are closely related to the degree of blood flow impairment depicted by rCBFVM maps 
which might therefore be more appropriate to detect penumbral flow than commonly used 
TTP maps. Pathophysiologically, these findings are consistent with what had been reported in 
studies on stroke patients using PET, the gold standard for imaging of cerebral oxygen 
metabolism. A negative correlation with cerebral blood flow in acute stroke was shown both 
17 
 
for OEF (with multitracer investigation, amongst others using 15O water)30 and relative 
hypoxia as indicated by increased uptake of 18F-Fluoromisonidazole (FMISO)31. The fact that 
the most pronounced changes of T2' and R2' can be found in the ischemic core is presumably 
due to an almost complete blood deoxygenation as a consequence of highly impaired blood 
flow. As T2'/R2' values also might be influenced to a certain extent by tissue iron content and 
fibre orientation32, ischemic necrosis with blood-brain barrier disruption, membrane 
disintegration and axonal damage might have an additional influence and partially explain the 
repealed relationship of these parameters with rCBF in the ischemic core. 
 
In summary, our study shows the close association between rCBF values based on the 
vascular model and T2'/R2' as MRI-based surrogates of increased OEF in acute stroke 
providing pathophysiologically plausible results. Furthermore, the correlation of T2' and R2' 
with rCBF suggests rCBF as a more reliable parameter than TTP to estimate penumbra and 
oligemia in ischemic stroke. However, rCBF should be corrected for macrovascular 
components as performed in this study. 
 
 
Limitations 
This study has several limitations. Although the application of a postprocessing procedure for 
DSC data with the vascular model is advantageous in terms of avoidance of interpolation and 
theoretically should result in more reliable relative CBF data, displaying these data in 
dimensionless numbers makes it currently difficult to compare them to perfusion values 
obtained with established deconvolution methods. A validation of the vascular model against 
these conventional algorithms and PET measurements of cerebral perfusion will be required 
to judge their quantitative properties. As grey and white matter can be expected to differ in 
terms of infarction thresholds in DWI as well as viability thresholds for hypoperfusion and 
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oxygen consumption, a segmentation of both the PWI and the T2'/R2' data would be 
desirable. However, as anatomic imaging appropriate for segmentation is time-consuming, we 
did not acquire 3D T1-weighted sequences (e.g. MPRAGE) in our protocol to avoid delay of 
reperfusion therapy. It should be noted that a ROI-based approach was chosen for assessing 
potential correlations between T2' and perfusion parameters. A voxel-wise approach was not 
deemed to be feasible as the T2' maps are relatively noisy. This is due to the fact that R2' is 
defined as the difference between R2* and R2. In the absence of major static magnetic field 
distortions, R2* will approach R2, so R2' will tend towards zero, thus yielding erroneously 
high values of T2'=1/R2'. To avoid outliers, a maximum threshold of 300 ms was chosen for 
T2' values. Even so, for T2* being close to T2, noise will have a marked impact on the 
resulting T2' values which accounts for the reduced SNR in these maps. Consequently, the 
currently available T2' maps cannot be used to directly delineate areas with certain ranges of 
T2' values to determine thresholds of elevated deoxyhemoglobin concentration potentially 
defining the penumbra. Rather, this study confirms the pathophysiological assumptions 
associated with the use of the relaxation parameters T2' and R2' in ischemic stroke and 
encourages further research to improve these methods. However, at the current time-point, the 
immediate application as a clinical tool is not proposed, in view of the relatively high drop-
out rate (about 50%). Nonetheless, it should be noted that high-resolution quantitative 
oxygenation-sensitive T2’/R2’ maps as used in this study are difficult to obtain in the setting 
of hyperacute stroke, thus necessitating improved postprocessing algorithms such as the 
proposed method. Additionally, the exclusion rate in this study is also the result of 
comprehensive data evaluation which was deemed necessary because of the sensitivity to 
artifacts and the complexity of determining rCBF with DSC. A validation of these findings 
with PET as the reference method for imaging oxygen metabolism in larger patient collectives 
would be of interest. 
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Conclusions 
In conclusion, this study has shown the potential and pathophysiological plausibility of 
combining rCBF maps based on the vascular model with T2' and R2' mapping to detect local 
hypoperfusion and microvascular deoxygenation in acute ischemic stroke. Further research to 
refine and validate these techniques may enable their use as MRI-based surrogate markers of 
the ischemic penumbra for selecting stroke patients for interventional treatment strategies.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
Acknowledgements 
None. 
 
Funding acknowledgements 
NPB was funded by EPSRC grant EP/K025716/1. J.C.K. receives funding from Parkinson’s 
UK, the Monument Trust, and the National Institute for Health Research (NIHR). 
 
Author contribution statement 
A.S., N.P.B., R.D., U.N. O.C.S., M.A.C., J.C.K. and M.W. designed the study. A.S., R.D., 
U.N., O.C.S. and M.W. performed the MRI measurements. R.D. and U.N. developed the 
quantitative MRI sequences and the motion correction algorithm. M.A.C. provided the tool 
used for the calculation of rCBF values based on the vascular model. A.S., N.P.B., M.A.C., 
J.C.K. and M.W. analyzed the data and performed statistical analysis. A.S., N.P.B., R.D., 
U.N. O.C.S., M.A.C., J.C.K. and M.W. wrote the manuscript. J.C.K. and M.W. contributed 
equally to this work. 
 
Disclosures/Conflicts of Interest 
M.A.C. received royalties from the commercial licensing of FSL. All other authors declare 
that they have no conflict of interest. 
 
Supplementary material for this paper is available at: 
http://jcbfm.sagepub.com/content/by/supplemental-data.   
 
 
21 
 
References 
1. Baron JC, Bousser MG, Comar D, Soussaline F and Castaigne P. Noninvasive 
tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, 
limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol. 1981; 20: 
273-84. 
2. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke 
treatment. Cerebrovasc Dis. 1999; 9: 193-201. 
3. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb 
Blood Flow Metab. 2000; 20: 1276-93. 
4. Jensen-Kondering U and Baron JC. Oxygen imaging by MRI: can blood oxygen level-
dependent imaging depict the ischemic penumbra? Stroke. 2012; 43: 2264-9. 
5. Dani KA and Warach S. Metabolic imaging of ischemic stroke: the present and future. 
AJNR Am J Neuroradiol. 2014; 35: S37-43. 
6. An H, Ford AL, Vo KD, et al. Imaging Oxygen Metabolism In Acute Stroke Using 
MRI. Curr Radiol Rep. 2014; 2: 39. 
7. Sobesky J, Zaro Weber O, Lehnhardt FG, et al. Does the mismatch match the 
penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic 
stroke. Stroke. 2005; 36: 980-5. 
8. Sobesky J. Refining the mismatch concept in acute stroke: lessons learned from PET 
and MRI. J Cereb Blood Flow Metab. 2012; 32: 1416-25. 
9. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-
vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. 
Lancet. 2016; 387: 1723-31. 
10. Sobesky J. Leaving the black box approach: individualized prediction of recanalization 
benefit by advanced imaging in acute stroke. J Cereb Blood Flow Metab. 2015; 35: 1396. 
22 
 
11. Wagner M, Jurcoane A, Volz S, et al. Age-related changes of cerebral autoregulation: 
new insights with quantitative T2'-mapping and pulsed arterial spin-labeling MR imaging. 
AJNR Am J Neuroradiol. 2012; 33: 2081-7. 
12. Wagner M, Magerkurth J, Volz S, et al. T2'- and PASL-based perfusion mapping at 3 
Tesla: influence of oxygen-ventilation on cerebral autoregulation. J Magn Reson Imaging. 
2012; 36: 1347-52. 
13. Hirsch NM, Toth V, Forschler A, Kooijman H, Zimmer C and Preibisch C. Technical 
considerations on the validity of blood oxygenation level-dependent-based MR assessment of 
vascular deoxygenation. NMR Biomed. 2014; 27: 853-62. 
14. Geisler BS, Brandhoff F, Fiehler J, et al. Blood-oxygen-level-dependent MRI allows 
metabolic description of tissue at risk in acute stroke patients. Stroke. 2006; 37: 1778-84. 
15. Bauer S, Wagner M, Seiler A, et al. Quantitative T2'-mapping in acute ischemic 
stroke. Stroke. 2014; 45: 3280-6. 
16. Heiss WD and Zaro Weber O. Uncertainties in the assessment of cortical flow by 
perfusion-weighted MRI in acute stroke. Cerebrovasc Dis. 2011; 32: 194-5; author reply 6. 
17. Mouridsen K, Friston K, Hjort N, Gyldensted L, Ostergaard L and Kiebel S. Bayesian 
estimation of cerebral perfusion using a physiological model of microvasculature. 
Neuroimage. 2006; 33: 570-9. 
18. Chappell MA, Mehndiratta A and Calamante F. Correcting for large vessel 
contamination in dynamic susceptibility contrast perfusion MRI by extension to a 
physiological model of the vasculature. Magn Reson Med. 2014. 
19. Noth U, Volz S, Hattingen E and Deichmann R. An improved method for 
retrospective motion correction in quantitative T2* mapping. Neuroimage. 2014; 92: 106-19. 
20. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002; 17: 143-
55. 
23 
 
21. Jenkinson M, Bannister P, Brady M and Smith S. Improved optimization for the robust 
and accurate linear registration and motion correction of brain images. Neuroimage. 2002; 17: 
825-41. 
22. Ebinger M, Brunecker P, Jungehulsing GJ, et al. Reliable perfusion maps in stroke 
MRI using arterial input functions derived from distal middle cerebral artery branches. Stroke. 
2010; 41: 95-101. 
23. Zaro-Weber O, Moeller-Hartmann W, Heiss WD and Sobesky J. MRI perfusion maps 
in acute stroke validated with 15O-water positron emission tomography. Stroke. 2010; 41: 
443-9. 
24. Dani KA, Thomas RG, Chappell FM, et al. Computed tomography and magnetic 
resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol. 
2011; 70: 384-401. 
25. Ostergaard L, Chesler DA, Weisskoff RM, Sorensen AG and Rosen BR. Modeling 
cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb 
Blood Flow Metab. 1999; 19: 690-9. 
26. Jensen UR, Liu JR, Eschenfelder C, et al. The correlation between quantitative T2' and 
regional cerebral blood flow after acute brain ischemia in early reperfusion as demonstrated in 
a middle cerebral artery occlusion/reperfusion model of the rat. J Neurosci Methods. 2009; 
178: 55-8. 
27. Singer OC, de Rochemont Rdu M, Foerch C, et al. Relation between relative cerebral 
blood flow, relative cerebral blood volume, and mean transit time in patients with acute 
ischemic stroke determined by perfusion-weighted MRI. J Cereb Blood Flow Metab. 2003; 
23: 605-11. 
28. Seiler A, Deichmann R, Noth U, et al. Oxygenation-Sensitive Magnetic Resonance 
Imaging in Acute Ischemic Stroke Using T2'/R2' Mapping: Influence of Relative Cerebral 
Blood Volume. Stroke. 2017. 
24 
 
29. Christen T, Schmiedeskamp H, Straka M, Bammer R and Zaharchuk G. Measuring 
brain oxygenation in humans using a multiparametric quantitative blood oxygenation level 
dependent MRI approach. Magn Reson Med. 2012; 68: 905-11. 
30. Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S and Crouzel C. Local brain 
haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission 
tomography. Brain. 1989; 112 ( Pt 4): 931-51. 
31. Alawneh JA, Moustafa RR, Marrapu ST, et al. Diffusion and perfusion correlates of 
the 18F-MISO PET lesion in acute stroke: pilot study. Eur J Nucl Med Mol Imaging. 2014; 
41: 736-44. 
32. Sedlacik J, Boelmans K, Lobel U, Holst B, Siemonsen S and Fiehler J. Reversible, 
irreversible and effective transverse relaxation rates in normal aging brain at 3T. Neuroimage. 
2014; 84: 1032-41. 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
Figure legends 
 
Figure 1. A: Mask depicting the large vessels based on signal variance across time in the PWI 
time series. This mask was reduced to the anterior circulation of the unaffected side (B) in to 
select voxels for the determination of the AIF shape. These voxels overlaid on the PWI raw 
data (B) show good agreement with the MCA branches of the Sylvian segment and the 
cortical branches (M2 and M3 segment). C: rCBF map after processing of PWI raw data using 
the vascular model. Note that after correction for macrovascular components and applying the 
vessel mask, high-flow components reflecting large arterial vessels are removed (D) as 
indicated by the scale bars (C, D). rCBF values are given as non-dimensional numbers as 
exported by ‘VERBENA’. 
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Figure 2. Upper row: illustration of ROI placement. The infarct core was defined as the 
hypointense areas on ADC maps with a threshold of <550 s/mm2. The infarct core was 
subtracted from the TTP lesion to receive the DWI/PWI mismatch area that was further 
subdivided into three ROIs in anterior-posterior direction. Lower row: representative images 
of a patient from one slice above the ischemic core. The mask for the TTP lesion is overlaid 
on the rCBF map (light blue). rCBF values within this area are heterogeneous showing a clear 
reduction in the left periventricular white matter. T2'/R2' map show an area with decreased 
T2'/increased R2' corresponding to the area of restricted flow. Correspondingly, T2' is 
increased and R2' decreased on the opposite side, indicating sufficient or high oxygen supply 
in well-perfused tissue. Parameter maps are corrected for large vessels as explained in the 
Methods section. ADC: apparent diffusion coefficient; mm: millimeters; s: seconds; TTP: 
time-to-peak; rCBF: relative cerebral blood flow; VM: vascular model; ms: milliseconds. 
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Figure 3. Flow diagram schematically illustrating the different steps of data analysis and 
selection for final analysis. aThe methods applied for initial data evaluation and assessment 
for artefacts are explained in detail in the Supplementary material. bQuality of AIF was 
assessed based on different characteristics of the signal-time curves. Detailed descriptions of 
the methods and results can be found in the Supplementary material.  
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Figure 4. Scatterplots for T2' values obtained from the entire (A, B) and the subdivided (C, 
D) mismatch area plotted against rCBFVM and rCBFSVD. Significant correlations were found 
between T2' and rCBFVM. rCBF: relative cerebral blood flow; VM: vascular model; SVD: 
singular value deconvolution; ms: milliseconds; mL: milliliters; g: grams; min: minute. 
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Tables  
Table 1. Demographic and clinical baseline data. 
Patient 
No. 
Age, 
y/Sex 
Affected 
Hemisphere 
Site of 
Occlusion 
Initial 
NIHSS 
Onset-to-MRI time 
[min] 
1 44/F Left ICA and MCA 30 238 
2 69/M Right MCA M1 15 204 
3 77/M Right MCA M1 14 300 
4 72/F Left ICA and MCA 20 400 
5 69/F Left MCA M1 17 272 
6 84/F Right MCA M1 6 223 
7 50/M Right ICA and MCA 12 256 
8 82/M Left MCA M1 8 293 
9 80/F Right ICA and MCA 18 191 
10 60/F Left MCA M2 8 ... 
11 73/F Left MCA M1 6 ... 
 
ICA: internal carotid artery; MCA: middle cerebral artery; exact time of symptom onset was 
not assessable in 2 patients. 
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Table 2. Mean values (± standard deviations) for T2'/R2' and rCBFVM in the respective 
regions-of-interest and corresponding contralateral areas. 
 T2' [ms] R2' [s-1] rCBFVM 
ROI 
 
Affected 
 
 
Unaffected 
 
p-value 
 
Affected 
 
 
Unaffected 
 
 
p-value 
 
Affected Unaffected p-value 
Ischemic 
core 
88.07±17.52 106±14.62 0.004 14.48±3.37 12.04±2.26 0.01 0.047±0.028 0.096±0.039 0.004 
Mismatch 92.94±13.22 102.45±14.19 0.01 10.97±1.65 9.96±1.41 0.01 0.072±0.028 0.09±0.033 0.005 
Rostral 103.95±8.22 114.05±6.9 0.011 12.36±.37 10.82±1.06 0.021 0.068±0.027 0.1±0.037 0.008 
Middle 100.58±10.37 109.93±11.01 0.01 12.29±1.57 10.88±1.2 0.003 0.065±0.034 0.084±0.035 0.01 
Dorsal 99.02±11.88 111.09±10.89 0.004 12.25±1.5 10.76±1.08 0.004 0.086±0.03 0.095±0.034 0.026 
 
ROI: region-of-interest; ms: milliseconds; s: seconds. 
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Supplementary material 
 
 
Assessment of quantitative maps for artifacts 
 
Four patients out of twenty-one were excluded from further analysis because the quality of the quantitative T2, T2* and consequently the resulting T2' maps was 
compromised by artifacts. The T2' maps of these four patients that showed a high artifact load on visual inspection are given in the Supplemental figure II. Two different 
methods were used to systematically analyze the presence of misleading artifacts in these patients.  
 
1) The T2* maps were assessed for motion artifacts by calculating for each subject the empirical correlation coefficient between the data values in the 
respective T2* map and the T2-weighted anatomical reference (which was derived from the data acquired for T2 mapping). The rationale is that there 
should be a positive correlation between these data sets since contrasts are basically similar: fluid compartments yield increased T2* values and high 
intensities in T2-weighted anatomies, whereas iron-rich (deoxygenated hemoglobin) compartments yield local hypointensity in both data sets. In 
contrast, motion artifacts rather manifest themselves as spurious hyper- and hypointense structures in the T2* map which do not have a counterpart in 
the anatomical data, thus reducing correlations. The correlation coefficient (corr) was derived for each subject and the median value (median) and 
standard deviation (SD) across all values of corr was calculated. Subsequently, subjects were excluded from the analysis if corr was below a threshold 
which was chosen as median-SD. Data for both groups are given in the Supplemental table I. 
 
 
2) In order to analyze the dispersion of the quantitative T2, T2* and T2' values as an indicator of major artifacts leading to erroneous quantitative values, 
we defined for each patient a region-of-interest (ROI) in the paraventricular white matter of the unaffected hemisphere which was part of the target 
region for analysis in all patients. As measures of skewed distribution, we extracted the SD and the coefficient of variation (CoV, SD/mean) of T2, T2* 
and T2' from these ROIs (Supplemental figure III) as we expected SD and CoV to be substantially higher if the data is affected by artefacts. Subjects 
were excluded from the analysis if SD or CoV exceeded a threshold value of median + 2 SD of the subjects without major artifacts on visual inspection.  
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Evaluation of PWI raw data quality and sufficiency of bolus arrival 
On the whole, six patients were excluded from final anaylsis due to insufficient quality of the PWI data (two patients with poor quality data after initial evaluation and a 
further four patients with intermediate quality data in a second step, also see flow diagram Figure 3 in the main text).  
 
1) After initial evaluation of the PWI timeseries, insufficient bolus arrival leading to failure of the postprocessing algorithms was suspected in two patients 
(sequential numbers 003 and 011). For a detailed analysis of the signal-time curve characteristics, voxels were selected from the proximal middle 
cerebral artery of the unaffected side to determine the shape of a potential arterial input function (AIF). Signal-time curves in these patients showed a 
high amount of noise in the baseline signal (Supplemental figure IV). While a slight signal decrease could be seen after arrival of the contrast agent 
bolus, no distinct peak was present in the timeseries (Supplemental figure IV). In order to objectify these properties, we calculated the standard 
deviation (SD) of the baseline signal, the signal-to-noise ratio (SNR), the amplitude of the contrast bolus-induced signal decrease and the ratio of the 
signal decrease divided by the SD of the baseline signal. The SNR was calculated according to a standard method given in the literature1. The 
supplemental figure V shows these characteristics for the two patients in comparison to the eleven patients that were included in the final analysis and 
the four patients with intermediate quality PWI data that were excluded in a second step after a more detailed evaluation. Subjects were excluded from 
further analysis if one of these parameters was beyond a threshold of mean ± 2 SD from the final analysis group and the intermediate quality group.    
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2) Since the determination of relative cerebral blood flow (rCBF) with dynamic susceptibility contrast (DSC) PWI is technically critical, we aimed to select 
only good quality AIFs conforming to the visual criteria specified in the Methods section of the main text. An example of an AIF complying with these 
criteria can be found in the Supplemental figure I. According to these criteria, a further four patients (sequential numbers 001, 015, 019 and 020) were 
excluded from the final analysis (flow diagram Figure 3 in the main text). Representative rCBF maps and AIFs for these patients can be found in the 
Supplemental figure VI. Apart from the subjective criteria, we used objective measures such as the bolus arrival time (Td), time to peak (TTP) and peak 
height (Pmax) to assess the AIF quality. These criteria proposed in the literature2, 3 were complemented with additional conditions: the time of signal 
decrease (calculated as the time from the beginning to the maximum of the peak) and the time of signal re-increase (time from the peak maximum to re-
arrival of the signal at baseline/at a stable level) as measures of steepness of the peak on both sides. Furthermore, we calculated peak width, the ratio 
peak height/width as a measure of peak ‘sharpness’ and the percentage of signal return to baseline (calculated as signal intensity post peak/signal 
intensity pre peak x 100 %). The eleven patients included in the final analysis (good quality AIF) had significantly shorter Td (p<0.05) and TTP 
(p=0.001) as well as shorter time of signal decrease (p<0.01), time of signal re-increase (p<0.05) and a smaller peak width (p<0.05). In addition, these 
patients showed a higher percentage of signal return to baseline (p=0.006) and a greater peak ‘sharpness’ (p=0.003) compared to the four patients that 
were excluded on the basis of these criteria (Supplemental table II). Pmax was larger in the final analysis group with a strong trend to significance 
(p=0.078, Supplemental figure V, C). Subjects were excluded from further analysis if one of these parameters was beyond a threshold of mean ± 2SD. 
Each of the four excluded patients showed mean values outside of the range mean ± 2 SD of the good quality group for at least five of these parameters. 
Finally, also SNR in the final analysis group was significantly higher (p<0.05) than in the four patients with intermediate quality AIF (Supplemental 
figure V, B).  
 
 
 
Supplemental table I. Correlation coefficients of T2* maps with the anatomical reference (T2) for seventeen patients with uncompromised quantitative maps (A) and the 
four patients that were excluded because the T2* maps were strongly affected by artifacts (B).     
 
   A)                                                                  B)                                                   
Sequential 
subject No. Corr 
 001 0.322381 
002 0.301653 
003 0.209359 
004 0.252941 
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005 0.172140 
007 0.157517 
008 0.229931 
009 0.214240 
010 0.271880 
011 0.276973 
012 0.293664 
013 0.168414 
014 0.233809 
015 0.254706 
016 0.271124 
019 0.300202 
020 0.240268 
Median 0.233809 
SD 0.085325 
Lower 
limit 
(Median-
SD) 
0.148484 
 
 
The sequential number is given for each patient. Note that correlation coefficients for each of the excluded patients in table B) are below the lower limit of median-SD of the 
data in table A). Corr differs significantly between the two groups (p=0.0001). Statistical significance for group differences was evaluated by using the Mann-Whitney U test 
for independent samples. 
 
 
 
Supplemental table II. Mean values ± SD of AIF selection criteria for the final analysis group and the four patients excluded because of intermediate AIF quality. 
 
Sequential 
subject No. Corr 
006 0.029159 
017 0.012328 
018 0.112011 
021 0.142847 
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Selection 
criterion 
Bolus arrival time (Td) [s] Time of signal decrease [s] Time of signal re-increase [s] Peak width [s] 
Patient 
group 
Good quality 
(n=11) 
Intermediate 
quality (n=4) 
Good quality 
(n=11) 
Intermediate quality 
(n=4) 
Good quality 
(n=11) 
Intermediate quality 
(n=4) 
Good quality 
(n=11) 
Intermediate quality 
(n=4) 
Mean ±SD 20.7 ± 2.63 26.25 ± 6.08 5.46 ± 2.02 13 ± 2.83 10.09 ± 3.72 17 ± 3.61 15.64 ± 4.78 25.75 ± 8.06  
p-value 0.036 0.003 0.022 0.040 
 
 
 
Selection 
criterion Time to peak (TTP) [s] Peak ‘sharpness‘ (height/width) [s
-1] Signal return to baseline [%] 
Patient 
group 
Good quality 
(n=11) 
Intermediate quality 
(n=4) 
Good quality 
(n=11) 
Intermediate quality 
(n=4) 
Good quality 
(n=11) 
Intermediate quality 
(n=4) 
Mean ± SD 24.27 ± 7.91 39.25 ± 7.27 21.66 ± 8.86 8.11 ± 2.02 93.17 ± 4.29 80.05 ± 7.58 
p-value 0.001 0.003 0.006 
 
s: seconds. Statistical significance for group differences was evaluated by using the Mann-Whitney U test for independent samples.   
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Supplemental figures 
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Supplemental figure I. Example of a signal-time curve (arbitrary units) used as an AIF for a representative patient. Note the sharp and distinct peak and the relatively low 
baseline noise level. t: time; s: seconds. 
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Supplemental figure II. T2' maps of the four patients (sequential numbers given in the Supplemental table B) that were excluded due to major artifacts. Note the pronounced 
blurring of anatomical structures and the presence of variantly occurring hypo- and hyperintensities. In No.3, the impact of motion-related artifacts on the quantitative T2 and 
T2* data was very pronounced and resulted in a failure of the coregistration of T2 to T2*, leading to an incomplete representation of brain structures on the T2' map. 
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Supplemental figure III. Boxplots displaying standard deviations (SD, given in milliseconds) and coefficients of variation of T2, T2* and T2' for the four patients with 
strongly motion-affected quantitative imaging data and the patients without major artifacts on visual inspection. For these measurements, quantitative maps were used without 
any threshold. SD and CoV of each parameter were significantly higher for the excluded patients indicating a more skewed distribution of values due to a strong influence of 
artifacts leading to erroneous values. Statistical significance for group differences was evaluated by using the Mann-Whitney U test for independent samples. 
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Supplemental figure IV. Signal-time curves for the initially excluded two patients with insufficient bolus arrival. A high level of noise is evident and while a small 
Gadolinium-induced signal decrease is visible, no distinct peak is present. Signal intensities are given in arbitrary units. s: seconds. 
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Supplemental figure V. Boxplots for different characteristics of the PWI signal-time curves stratified according to the different patient groups (patients excluded initially 
(n=2), excluded after detailed AIF evaluation (n=4) and patients included in the final analysis (n=11)). The mean values for the SD of the baseline signal and the ratio signal 
decrease / SD of the baseline signal from the initially excluded two patients was beyond the range mean ± 2 SD of the final analysis and the intermediate quality group (panels 
A and D), indicating a high level of baseline noise and that the amplitude of the contrast bolus-induced signal decay in these patients was not appreciably larger than the 
amplitude of the baseline noise. Parameters differed significantly between the two patients with insufficient bolus and the final analysis group, except for the amplitude of the 
signal decrease (peak height for the final analysis and the intermediate quality group, panel D). Values (calculated from signal intensities) in panels A, C and D are given in 
arbitrary units. Statistical significance for group differences was evaluated by using the Mann-Whitney U test for independent samples. SD: standard deviation. 
 
 
 
 49 
 
 
 50 
 
          
   
Supplemental figure VI. Maps of deconvolved rCBF and rCBF calculated using the vascular model (with and without correction for macrovascular components) as well as 
arterial input functions for the affected and unaffected side for the 4 patients that were excluded from final analysis based on a detailed quantitative analysis of signal-time 
curve characteristics. Signal intensity is given in arbitrary units. rCBF: relative cerebral blood flow; VM: vascular model; SVD: singular value deconvolution; AIF: arterial 
input function; s: seconds.        
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Supplemental figure VII. R2' values from ROIs of the entire (A, B) and the subdivided (C, D) mismatch area plotted against rCBFVM and rCBFSVD values. Significant 
correlations were found between R2' and rCBFVM.  rCBF: relative cerebral blood flow; VM: vascular model; SVD: singular value deconvolution; ms: milliseconds; s: 
seconds; mL: milliliters; g: grams; min: minute. 
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Supplemental figure VIII. Relationship between conventional rCBFSVD and rCBFVM based on the vascular model within the ROIs defined by subdivision of the mismatch 
area. A: rCBFVM values plotted against rCBFSVD values. B: scatterplot of the relative rCBF reduction within hypoperfused tissue, given in %reduction in relation to the 
respective corresponding contralateral area in the unaffected hemisphere. rCBF: relative cerebral blood flow; VM: vascular model; SVD: singular value deconvolution; mL: 
milliliters; g: grams; min: minute.  
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